SLC2A1 and neoplasm: Increases in neutrophil, platelet, and monocyte counts in relation to lymphocyte counts were generally correlated with an advanced stage, tumor aggressiveness, and markers of tumor metabolic activity, e.g., SUVmax and GLUT1 expression.